Haleon (HLN)

Healthcare · Drug Manufacturers - Specialty & Generic
$8.87 +0.57% on the day Market cap $40.1B 52-week range $8.65 to $11.28 Prices as of Oct 7, 2026

What the price implies

A reverse DCF: instead of guessing a fair value, it asks what growth today's price already assumes. How it works.

Haleon's free cash flow isn't comparable to its market value here, so a cash-flow reverse DCF doesn't give a meaningful answer. The Modeling tab works from revenue and margins instead.

Fundamental grade

C

Five factors scored 1 to 9 from HLN's latest numbers, weighted into one grade. It describes the business, not whether the stock is a buy.

Valuation6
Profitability7
Growth4
Financial health3
Cash efficiency9

Key numbers

P/E (trailing)18.5x
P/E (forward)16.5x
Price / free cash flow20.3x
EV / EBITDA12.8x
Price / sales3.62x
Price / book1.78x
Revenue growth-1.8%
Operating margin21.9%
Net margin15.1%
Return on equity10.2%
Dividend yield0.78%
Debt / equity0.98x

Results from SEC filings

Fiscal years, from Haleon's 10-K filings. The deep dive has 15+ years, quarters and every line.

Fiscal year20212022202320242025
Revenue$9.5B$10.9B$11.3B$11.2B$11.0B
Net income$1.4B$1.1B$1.0B$1.4B$1.7B
Free cash flow$1.1B$1.7B$1.8B$2.0B$2.2B
EPS (diluted)$0.15$0.12$0.11$0.16$0.18
Operating margin17.2%16.8%17.7%19.6%21.9%

Where the revenue comes from

Revenue by products, fiscal 2025.

Oral Health$3.5B31%
Pain Relief$2.6B23%
Respiratory Health$1.9B17%
Vitamins, Minerals and Supplements$1.7B15%
Digestive Health$987M9%
Therapeutic Skin Health and Other$460M4%

Superinvestors who own HLN

From each investor's latest 13F filing (what a 13F shows). 8 of the investors we track hold it.

InvestorLast quarterValue% of portfolioQuarter
Dodge & Cox
Dodge & Cox
Added $1.4B0.73%Q2 2026
Hersh Cohen
ClearBridge Investments
Added $302M0.25%Q2 2026
Bill Nygren
Harris Associates LP
Added $157M0.21%Q2 2026
Jean-Marie Eveillard
First Eagle Investment Management
Added $39M0.07%Q2 2026
Cliff Asness
AQR Capital Management
Added $3M0.00%Q2 2026
Tweedy, Browne
Tweedy, Browne Company
Trimmed $672,0870.05%Q2 2026
Thomas Kahn
Kahn Brothers Group
Added $544,3210.09%Q2 2026
Murray Stahl
Horizon Kinetics LLC
Trimmed $116,0090.00%Q2 2026

Insider buying

Open-market purchases by Haleon's executives and directors in the last 12 months, from SEC Form 4 filings. What insider buying tells you.

No open-market insider purchases of HLN in the last 12 months. Most insider activity is selling and option exercises, which aren't shown here.

Get an alert at your buy price

Pick the price you'd be interested at. We'll email you when HLN trades at or below it.

$

Free accounts get 3 price alerts. No card needed.

In the full deep dive

DCF fair value per share
Yearly return (IRR) at today's price
Growth implied by revenue and margins
15+ years of statements and quarters

Questions

Are Haleon insiders buying the stock?

No open-market insider purchases of HLN in the last 12 months, according to SEC Form 4 filings.

Which superinvestors own Haleon?

8 of the superinvestors Investingly tracks hold HLN in their latest 13F, including Dodge & Cox, Hersh Cohen, Bill Nygren.

Prices and ratios as of Oct 7, 2026; statements from SEC filings. Information only, not investment advice. Superinvestor holdings come from 13F filings, which are filed up to 45 days after each quarter ends.